NCT06199544

Effect of Unani Medicine for the Management of Anomalies Associated With Polycystic Ovarian Syndrome

Effect of Unani Medicine Coded Formulations for the Management of Anomalies Associated With Polycystic Ovarian Syndrome

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 150 (estimated)
• Sponsor: Hamdard University · Academic / Other
• Sex: Female
• Age: 18 Years – 38 Years
• Healthy volunteers: Not accepted

Summary

Currently available medications for PCOS are symptom(s) oriented but have limitations because of its complex pathophysiology. The most preferred drug against PCOS is metformin which act as an insulin sensitizer to improve insulin-glucose metabolism and anovulatory cycles in PCOS. However, its use is associated with various side effects such as bloating, diarrhea and nausea. Thus, it is imperative to explore various other alternatives to combat this gynecological problem.

Detailed description

Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in reproductive age women, with a prevalence between 5%-15%. Currently, sedentary lifestyle, excessive intake of junk food and increasing prevalence of obesity has been associated with rise in the incidence of PCOS.

Conditions

• Comparative Study

Interventions

Type	Name	Description
DRUG	Metformin	Comparing the effect of drugs on symptoms of PCOS

Timeline

• Start date: 2022-10-01
• Primary completion: 2024-06-01
• Completion: 2024-12-01
• First posted: 2024-01-10
• Last updated: 2024-01-10

Locations

1 site across 1 country: Pakistan